NCT02917941View on ClinicalTrials.gov

A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Relapsed and/or Refractory Multiple Myeloma
Interventions
DRUG

Ixazomib

Ixazomib capsules

DRUG

Lenalidomide

Lenalidomide capsules

DRUG

Dexamethasone

Dexamethasone Tablets

Trial Locations (21)

Unknown

Nagoya

Narita

Shibukawa

Fukuyama

Kobe

Ibaraki

Sagamihara

Sendai

Ikoma

Sunto-gun

Utsunomiya

Bunkyo-ku

Koto-ku

Shibuya-ku

Shinjuku-ku

Tachikawa

Chiba

Fukuoka

Niigata

Okayama

Osaka

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY